跳至主要内容
临床试验/JPRN-UMIN000040109
JPRN-UMIN000040109已完成未知

Effect of Daily Ingestion of tea containing citrus ingredients on abdominal visceral fat area reduction: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison Study - Effect of Daily Ingestion of tea containing citrus ingredients on abdominal visceral fat area reduction

Hokkaido Information University0 个研究点目标入组 60 人开始时间: 2020年4月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Subjects who are under physician's advice, treatment, and/or medication for dyslipidemia and/or diabetes. 2. Pacemaker or defibrillator users. 3. Subject who disagree to cooperate with grip strength test and leg strength test at the time of screening test. 4. Subjects with familial hypercholesterolemia. 5. Subjects whose fasting blood glucose values are more than 126 mg/dl. 6. Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal diseases, and/or affected with infectious diseases requiring reports to the authorities. 7. Subjects with major surgical history relevant to the digestive system such as gastrectomy, gastrorrhaphy, enterectomy, etc. 8. Subjects with unusually high and/or low blood pressure and/or abnormal physical data and hematological data. 9. Subjects with severe anemia. 10. Pre- or post-menopausal women complaining of obvious physical changes. 11. Subjects s who regularly drink green tea. 12. Subjects who has high caffeine sensitivity.Subjects who are at risk of having allergic reactions to drugs or foods. 13. Subjects who has high caffeine sensitivity. 14. Subjects who regularly take medicine, functional foods, and/or supplements which would affect lipid metabolism. 15. Subjects who regularly take medicine, functional foods, and/or supplements which would affect glucose metabolism. 16. Heavy smokers, alcohol addicts or subjects with disordered lifestyle. 17. Subjects who donated either 400 ml whole blood within 16 weeks (women), 12 weeks (men), 200 ml whole blood within 4 weeks, or blood components within 2 weeks, prior to the current study. 18. Pregnant or lactating women or women who expect to be pregnant during this study. 19. Subjects who currently participate in other clinical trials, or participated within the last 4 weeks prior to the current study. 20. Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator.

研究者

相似试验